Preview Mode Links will not work in preview mode

Oct 20, 2022

Featuring an interview with Prof Sia Daneshmand, including the following topics:

  • Clinical presentation and initial evaluation of non-muscle-invasive urothelial bladder cancer (NMIBC) (0:00)
  • Alternative induction regimens when BCG is not available (4:06)
  • Treatment options for patients with BCG-refractory disease (8:46)
  • Role of immunotherapy in treating NMIBC (13:58)
  • Role of cystectomy in treating NMIBC (15:47)
  • Intravesical drug delivery for patients with muscle-invasive urothelial bladder cancer (MIBC) (20:37)
  • Dispelling myths and misperceptions about cystectomy and counseling eligible patients (26:19)
  • Neoadjuvant and adjuvant therapy for MIBC (37:40)

CME information and select publications